The research and industrialization of innovative drugs and high-end generic drugs is the maximization of the company's core technology and profits. At present, we are engaged in the research and development of targeted photodynamic innovative drugs and high-end generic drugs for the treatment of body surface tumors, tumor disease diagnosis and non-invasive treatment. Since the company’s establishment, our company has completed the research, process optimization, GMP commercial production of API and research of injection of two original target photodynamic drugs name as ASL-009 and ASL-018. The implementation and completion of the project has great economic benefits and practical value, which benefits the common people in China. The core technology of the project fills in the blank of domestic research in this field.